Skip to main content

Getinge AB Series B Value Stock - Dividend - Research Selection

Getinge

ISIN: SE0000202624 , WKN: 889714

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!

How our site works ...

✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month 
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgery and life sciences in the hospital, pharmaceutical and research sectors. The company reports in three segments: Acute Therapies (63% of sales), Surgical Workflows (27%) and Life Sciences (10%). Product areas include ventilators, surgical stents, life support systems, sterilizers, operating tables and sterile transfer systems. Getinge generates its sales from a broad geographic presence, with the Americas accounting for 45% of sales (33% of sales in the US), 25% in the Asia-Pacific region and the remaining 30% in Europe, the Middle East and Africa.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS